Trevena Inc

Trevena, Inc. (Pink Sheets: TRVN) is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with central nervous system (CNS) disorders. The company’s novel pipeline is based on Nobel Prize winning research and leverages groundbreaking science to address some of the most urgent diseases in CNS and beyond.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore pharmaceutical industry profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Trevena Inc.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Trevena, Inc. (Pink Sheets: TRVN) is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with central nervous system (CNS) disorders. The company’s novel pipeline is based on Nobel Prize winning research and leverages groundbreaking science to address some of the most urgent diseases in CNS and beyond.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.